JSNM2024/JSNMT2024

Presentation information

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 34:Animal Experiment 2

Fri. Nov 8, 2024 3:40 PM - 4:30 PM Room 5 (3F 302, Conference Center, PACIFICO Yokohama)

座長:小川 美香子(北海道大学 大学院薬学研究院)、西井 龍一(名古屋大学大学院医学系研究科 バイオメディカルイメージング情報科学)

[2-MO34-3] Therapeutic effect of211At-CD82 humanized chimeric antibody for acute myeloid leukaemia

Songji Zhao1、Noboru Oriuchi1、Taro Tachibana2、Ken-ichi Nishijima1、Chiaki Hata2、Naoyuki Ukon1、Cai-Xia Wang2、Akira Sugiyama3、Kohshin Washiyama1、Kazuhiro Takahashi1、Takayuki Ikezoe4 (1.Fukushima Medical Univertsity, Fukushima, Japan、2.Cell Engineering Corporation, Osaka, Japan、3.The University of Tokyo, Tokyo, Japan、4.Fukushima Medical University, Fukushima, Japan)

Abstract password authentication.

The password is listed on page 9 of the Program Book.

Password